Trial · NCT02476916
Registered outcomes34
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 34
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percentage of Participants Experiencing at Least One Adverse Event (AEs) in the Core Period | Up to Week 24 | An AE was defined as any untoward medical occurrence associated with the use of a drug in humans, whether or not considered study drug-related. |
| Secondary | Percentage of Participants Experiencing at Least One AE up to Month 102 | Up to Month 102 | An AE was defined as any untoward medical occurrence associated with the use of a drug in humans, whether or not considered study drug-related. Safety data for cumulative period (Core period and Extension period) has been reported in this outcome measure. |
| Secondary | Change From Baseline in Hemoglobin (Hb) Value at Week 24 | Baseline and Week 24 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Increased Hb values indicate improvement. |
| Secondary | Change From Baseline Hb Value up to Month 102 | Baseline, Months 12, 36, 60, 84, and 102 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Increased Hb values indicate improvement. |
| Secondary | Change From Baseline in Hematocrit at Week 24 | Baseline and Week 24 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Increased hematocrit values indicate improvement. |
| Secondary | Change From Baseline in Hematocrit up to Month 102 | Baseline, Months 12, 36, 60, 84, and 102 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Increased hematocrit values indicate improvement. |
| Secondary | Change From Baseline in Reticulocyte Count at Week 24 | Baseline and Week 24 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Decreased reticulocyte count values indicate improvement. |
| Secondary | Change From Baseline in Reticulocyte Count up to Month 102 | Baseline, Months 12, 36, 60, 84, and 102 | Change (absolute change) from baseline will be calculated as post-baseline value - baseline value. Decreased reticulocyte count values indicate improvement. |
| Secondary | Change From Baseline in Haptoglobin at Week 24 | Baseline and Week 24 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Increased haptoglobin values indicate improvement. |
| Secondary | Change From Baseline in Haptoglobin up to Month 102 | Baseline, Months 12, 36, 60, 84, and 102 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Increased haptoglobin values indicate improvement. |
| Secondary | Change From Baseline in Carboxyhemoglobin (COHb) at Week 24 | Baseline and Week 24 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Decreased COHb values indicate improvement. |
| Secondary | Change From Baseline in COHb up to Month 30 | Baseline, Months 12, 18, 24, and 30 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Decreased COHb values indicate improvement. |
| Secondary | Change From Baseline in Lactate Dehydrogenase (LDH) at Week 24 | Baseline and Week 24 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Decreased LDH values indicate improvement. |
| Secondary | Change From Baseline in LDH up to Month 30 | Baseline, Months 12, 18, 24, and 30 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Decreased LDH values indicate improvement. |
| Secondary | Change From Baseline in Total Bilirubin at Week 24 | Baseline and Week 24 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Decreased total bilirubin values indicate improvement. |
| Secondary | Change From Baseline in Total Bilirubin up to Month 102 | Baseline, Months 12, 36, 60, 84, and 102 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Decreased total bilirubin values indicate improvement. |
| Secondary | Change From Baseline in Indirect Bilirubin at Week 24 | Baseline and Week 24 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Decreased indirect bilirubin values indicate improvement. |
| Secondary | Change From Baseline in Indirect Bilirubin up to Month 102 | Baseline, Months 12, 36, 60, 84, and 102 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Decreased indirect bilirubin values indicate improvement. |
| Secondary | Change From Baseline in Erythropoietin (EPO) at Week 24 | Baseline and Week 24 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Decreased EPO values indicate improvement. |
| Secondary | Change From Baseline in (EPO) up to Month 30 | Baseline, Months 12, 18, 24, and 30 | Change (absolute change) from baseline was calculated as post-baseline value - baseline value. Decreased EPO values indicate improvement. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02476916/registered